3-Bromo-2-methyl-benzenesulfonyl chloride, 95.0%, 1g

N-Boc-2-(4-Aminophenyl)ethanol, 95.0%, 1g

5-(Hydroxymethyl)cytidine>95.0%(HPLC)200mg

1,3,5-Trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 100g

9,10-Dioxo-9,10-dihydro-anthracene-2,6-dicarboxylic acid, 97%, 250mg

3-NITRO-10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPINE, 90.0%, 100mg

5,5'-Oxybis(isobenzofuran-1,3-dione), 99.0%, 500g

4,4,5,5-Tetramethyl-2-(4-trifluoromethoxyphenyl)-1,3,2-dioxaborolane, 95.0%, 1g

6-Fluoro-2-quinolinemethanol, 95+%, 5g

L-Glutamine, 25 g

1-[4-(Trifluoromethyl)benzyl]cyclopropanecarboxylic acid, >95%, 1g

Station de pointe de pipette Mμlti® TipStation 0,1-10 μl longue portée, standard, non stérile, 4800 pièces

Ethyl 5-(4-Aminophenyl)oxazole-4-carboxylate, 95%, 100mg